David McGuinness
- Oncology top 2%
- Molecular Biology top 10%
- Cancer Research top 2%
- Public Health, Environmental and Occupational Health top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Talia GolanMichele ReniDaniel HochhauserDirk ArnoldEric Van CutsemHedy L. KindlerTeresa MacarullaMichael J. Hall
- Topics
- PARP inhibition in cancer therapy (18 papers)Pancreatic and Hepatic Oncology Research (12 papers)Healthcare Decision-Making and Restraints (10 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
David McGuinness
58 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 1.6k
- Molecular Biology 812
- Cancer Research 810
- Public Health, Environmental and Occupational Health 583
- Pulmonary and Respiratory Medicine 463
Countries citing papers authored by David McGuinness
This map shows the geographic impact of David McGuinness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McGuinness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McGuinness more than expected).
Fields of papers citing papers by David McGuinness
This network shows the impact of papers produced by David McGuinness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McGuinness. The network helps show where David McGuinness may publish in the future.
Co-authorship network of co-authors of David McGuinness
This figure shows the co-authorship network connecting the top 25 collaborators of David McGuinness. A scholar is included among the top collaborators of David McGuinness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McGuinness. David McGuinness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 120 | |
| 5 | 16 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 16 | |
| 9 | Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancerbreakdown → | 1468 |
| 10 | 33 | |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 7 | |
| 14 | 11 | |
| 15 | 66 | |
| 16 | 35 | |
| 17 | 64 | |
| 18 | 67 | |
| 19 | 39 | |
| 20 | 18 |
About David McGuinness
David McGuinness is a scholar working on Equine, Clinical Psychology and Oncology, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (18 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Healthcare Decision-Making and Restraints (10 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (810 citations) and Behavioral Neuroscience (83 citations). David McGuinness has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Talia Golan, Michele Reni, Daniel Hochhauser, Dirk Arnold, Eric Van Cutsem, Hedy L. Kindler, Teresa Macarulla, Michael J. Hall, Pascal Hammel and Gershon Y. Locker. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.